Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
Open Access
- 1 March 2020
- journal article
- review article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 14, 951-959
Abstract
The currently approved treatment for female pattern hair loss (FPHL) includes topical minoxidil administration; however, this treatment fails to achieve hair regrowth in some patients. Finasteride, a selective 5α-reductase inhibitor (5-ARI), may be considered as an alternative treatment. However, because of its potential teratogenic effects, clinical studies and use of finasteride for FPHL are limited. In this review, we aim to summarize the literature regarding the pharmacology, clinical efficacy, and adverse effects of oral finasteride for the treatment of FPHL and to provide novel therapeutic options including topical finasteride and dutasteride, a new generation 5-ARI, for the treatment of FPHL.Keywords
This publication has 53 references indexed in Scilit:
- Finasteride 5 mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal womenInternational Journal of Trichology, 2013
- Efficacy of Finasteride 1.25 mg on Female Pattern Hair Loss; Pilot StudyAnnals of Dermatology, 2012
- A woman with iatrogenic androgenetic alopecia responding to finasterideBritish Journal of Dermatology, 2007
- The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasterideJournal of the American Academy of Dermatology, 2006
- Evaluation and treatment of male and female pattern hair lossJournal of the American Academy of Dermatology, 2005
- Finasteride Treatment of Patterned Hair Loss in Normoandrogenic Postmenopausal WomenDermatology, 2004
- Finasteride for female androgenetic alopeciaBritish Journal of Dermatology, 2002
- Measuring Reversal of Hair Miniaturization in Androgenetic Alopecia by Follicular Counts in Horizontal Sections of Serial Scalp Biopsies: Results of Finasteride 1mg Treatment of Men and Postmenopausal WomenJournal of Investigative Dermatology Symposium Proceedings, 1999
- FinasterideDrugs, 1999
- Effects of Long Term Treatment With Finasteride (MK-906), a 5-Alpha Reductase Inhibitor, on Circulating LH, FSH, Prolactin and EstradiolHormone and Metabolic Research, 1992